, molécules antibactériennes ayant des effets sur les formes atypiques de Borrelia

J. F. Anderson and L. A. Magnarelli, Biology of Ticks, Infect Dis Clin North Am. juin, vol.22, issue.2, pp.195-215, 2008.

D. Rudolph and W. Knülle, Site and mechanism of water vapour uptake from the atmosphere in ixodid ticks, Nature. 3 mai, vol.249, issue.452, pp.84-89, 1974.

. Pérez-eid-c, Les tiques: identification, biologie, importance médicale et vétérinaire. Éd. Tec & Doc, vol.314, 2007.

J. S. Gray, Review The ecology of ticks transmitting Lyme borreliosis, Exp Appl Acarol, vol.22, issue.5, pp.249-258, 1998.

C. Guiguen and B. Degeilh, Les tiques d'intérêt médical : rôle vecteur et diagnose de laboratoire, Rev Fr Lab. déc, issue.338, pp.49-57, 2001.

G. J. and .. , Chastel c. Maladies vectorielles à tiques et modifications de l'écosystème en Lorraine, pp.95-100, 2002.

C. Boyard, Facteurs environnementaux de variation de l'abondance des tiques Ixodes ricinus dans des zones d'étude modèles en Auvergne

. Disponible,

F. Schramm, A. Grillon, D. Martino, S. , and J. B. La-borréliose-de-lyme, Rev Francoph Lab, vol.2013, issue.457, pp.35-49, 2013.

J. Hovius, M. Levi, and E. Fikrig, Salivating for Knowledge: Potential Pharmacological Agents in Tick Saliva, PLoS Med. 12 févr, vol.5, issue.2, p.43, 2008.

D. Clavé, Laboratoire de Bactériologie-Hygiène. Fiche bactérie : borrelia burgdorferi

. Chu-toulouse;-disponible-sur,

M. Schaller and U. Neubert, Ultrastructure ofBorrelia burgdorferi after exposure to benzylpenicillin, Infection, vol.22, issue.6, pp.401-406, 1994.

. Brorson-Øystein and S. Brorson, An in vitro study of the susceptibility of mobile and cystic forms Borrelia to metronidazole, APMIS. mars, vol.107, issue.1-6, pp.566-76, 1999.

A. Kersten, C. Poitschek, S. Rauch, and E. Aberer, Effects of penicillin, ceftriaxone, and doxycycline on morphology of Borrelia burgdorferi, Antimicrob Agents Chemother. mai, vol.39, issue.5, pp.1127-1160, 1995.

W. Burgdorfer and S. F. Hayes, Vector-spirochete relationships in louseborne and tick-borne borrelioses with emphasis on Lyme disease, Advances in Disease Vector Research, pp.127-50, 1990.

A. S?dziene, P. A. Rosa, P. A. Thompson, D. M. Hogan, and A. G. Barbour,

, Antibody-resistant mutants of Borrelia burgdorferi: in vitro selection and characterization, J Exp Med, vol.176, issue.3, pp.799-809, 1992.

A. Schwarzbach, A. Herranen, L. Gilbert, and L. Meril?inen, Morphological and biochemical features of Borrelia burgdorferi pleomorphic forms, Microbiology. 1 mars, vol.161, issue.3, pp.516-543, 2015.

V. P. Mursic, S. Reinhardt, B. Wilske, U. Busch, G. Wanner et al., Formation and cultivation ofBorrelia burgdorferi spheroplast-L-form variants, Infection, vol.24, issue.3, pp.218-226, 1996.

Ø. Brorson and . Brorson-s-h, A rapid method for generating cystic forms of Borrelia burgdorferi, and their reversal to mobile spirochetes, Apmis, vol.106, pp.1131-1141, 1998.

J. Miklossy, A. Kis, A. Radenovic, L. Miller, L. Forro et al., Beta-amyloid deposition and Alzheimer's type changes induced by Borrelia spirochetes, Neurobiol Aging. févr, vol.27, issue.2, pp.228-264, 2006.

J. A. Livengood and R. D. Gilmore, Invasion of human neuronal and glial cells by an infectious strain of Borrelia burgdorferi. Microbes Infect, vol.8, pp.2832-2872, 2006.

J. Miklossy, S. Kasas, A. D. Zurn, S. Mccall, S. Yu et al., Persisting atypical and cystic forms of Borrelia burgdorferi and local inflammation in Lyme neuroborreliosis, J Neuroinflammation, vol.5, issue.1, p.40, 2008.

D. O. Serra, A. M. Richter, G. Klauck, F. Mika, and R. Hengge, Microanatomy at Cellular Resolution and Spatial Order of Physiological Differentiation in a Bacterial Biofilm, mBio. 19 mars, vol.4, issue.2, pp.103-116, 2013.

A. G. Barbour, Isolation and cultivation of Lyme disease spirochetes, Yale J Biol Med, vol.57, issue.4, p.521, 1984.

E. Sapi, S. L. Bastian, C. M. Mpoy, S. Scott, A. Rattelle et al., Characterization of Biofilm Formation by Borrelia burgdorferi In Vitro. Forestier C, éditeur. PLoS ONE, vol.7, p.48277, 2012.

B. Troxell, H. Xu, and X. F. Yang, Borrelia burgdorferi, a Pathogen That Lacks Iron, Encodes Manganese-dependent Superoxide Dismutase Essential for Resistance to Streptonigrin, J Biol Chem. 1 juin, vol.287, issue.23, pp.19284-93, 2012.

C. M. Fraser, S. Casjens, W. M. Huang, G. G. Sutton, R. Clayton et al., Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi, Nature, vol.390, issue.6660, pp.580-586, 1997.

G. Baranton, D. Postic, S. Girons, I. Boerlin, P. Piffaretti et al., Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis, Int J Syst Evol Microbiol, vol.42, issue.3, pp.378-383, 1992.

A. Sadziene, D. D. Thomas, V. G. Bundoc, S. C. Holt, and A. G. Barbour, A flagellaless mutant of Borrelia burgdorferi. Structural, molecular, and in vitro functional characterization, J Clin Invest, vol.88, issue.1, p.82, 1991.

Y. Ge, C. Li, L. Corum, C. A. Slaughter, and N. W. Charon, Structure and expression of the FlaA periplasmic flagellar protein of Borrelia burgdorferi, J Bacteriol. mai, vol.180, issue.9, pp.2418-2443, 1998.

N. W. Charon, A. Cockburn, C. Li, J. Liu, K. A. Miller et al., The Unique Paradigm of Spirochete Motility and Chemotaxis, Annu Rev Microbiol, vol.66, issue.1, pp.349-70, 2012.

A. Mannelli, L. Bertolotti, L. Gern, and J. Gray, Ecology of Borrelia burgdorferi sensu lato in Europe: transmission dynamics in multi-host systems, influence of molecular processes and effects of climate change, FEMS Microbiol Rev. juill, vol.36, issue.4, pp.837-61, 2012.

T. J. Schuijt, J. Hovius, N. D. Van-burgel, N. Ramamoorthi, E. Fikrig et al., The Tick Salivary Protein Salp15 Inhibits the Killing of SerumSensitive Borrelia burgdorferi Sensu Lato Isolates, Infect Immun. 1 juill, vol.76, issue.7, pp.2888-94, 2008.

M. B. Lawrenz, J. M. Hardham, R. T. Owens, J. Nowakowski, A. C. Steere et al., Human antibody responses to VlsE antigenic variation protein of Borrelia burgdorferi, J Clin Microbiol, vol.37, issue.12, pp.3997-4004, 1999.

T. , , 2014.

A. G. Barbour, Plasmid analysis of Borrelia burgdorferi, the Lyme disease agent, J Clin Microbiol, vol.26, issue.3, pp.475-478, 1988.

P. Chouter and D. Christmann, Borréliose de Lyme : démarches diagnostiques, thérapeutiques et préventives, In Institut pasteur, p.60, 2007.

F. Schramm, Inflammation cutanée et borréliose de Lyme : étude in vitro des interactions entre les cellules résidentes de la peau et Borrelia

. Disponible,

R. R. Mullegger, T. K. Means, J. J. Shin, M. Lee, K. L. Jones et al., Chemokine Signatures in the Skin Disorders of Lyme Borreliosis in Europe: Predominance of CXCL9 and CXCL10 in Erythema Migrans and Acrodermatitis and CXCL13 in Lymphocytoma, Infect Immun. 1 sept, vol.75, issue.9, pp.4621-4629, 2007.

D. Lipsker, A. -. Bach, N. Hansmann, Y. Jaulhac, and B. , Long-term prognosis of patients treated for erythema migrans in France, Br J Dermatol, vol.146, issue.5, pp.872-876, 2002.

F. Strle and G. Stanek, Clinical manifestations and diagnosis of Lyme borreliosis, Lyme Borreliosis, 2009.

P. Oschmann, W. Dorndorf, C. Hornig, C. Schäfer, H. J. Wellensiek et al., Stages and syndromes of neuroborreliosis, J Neurol, vol.245, issue.5, pp.262-272, 1998.

L. Hansen-k and . Denmark, Brain, vol.115, issue.2, pp.399-423, 1992.

F. Schramm, Inflammation cutanée et borréliose de Lyme : étude in vitro des interactions entre les cellules résidentes de la peau et Borrelia

. Disponible,

J. D. Fisher, M. Feld, and S. Furman, Lyme carditis: an important cause of reversible heart block, Ann Intern Med, vol.110, pp.339-345, 1989.

E. Aberer and H. Klade, Cutaneous manifestations of Lyme borreliosis, Infection, vol.19, issue.4, pp.284-286, 1991.
DOI : 10.1007/bf01644968

I. Zalaudek, B. Leinweber, H. Kerl, and R. R. Müllegger, Acrodermatitis chronica atrophicans in a 15-year-old girl misdiagnosed as venous insufficiency for 6 years, J Am Acad Dermatol. juin, vol.52, issue.6, pp.1091-1095, 2005.
DOI : 10.1016/j.jaad.2005.01.125

D. Lipsker, Aspects dermatologiques au cours de la maladie de Lyme, Médecine Mal Infect. juill, vol.37, issue.7-8, pp.540-547, 2007.
DOI : 10.1016/j.medmal.2006.01.013

R. R. Müllegger and M. Glatz, Skin manifestations of Lyme borreliosis, Am J Clin Dermatol, vol.9, issue.6, pp.355-368, 2008.

E. Kindstrand, B. Y. Nilsson, A. Hovmark, and R. Pirskanen, Peripheral neuropathy in acrodermatitis chronica atrophicans-effect of treatment, Acta Neurol Scand, vol.106, issue.5, pp.253-257, 2002.

M. W. Pound and D. B. May, Proposed mechanisms and preventative options of Jarisch-Herxheimer reactions, J Clin Pharm Ther, vol.30, issue.3, pp.291-295, 2005.
DOI : 10.1111/j.1365-2710.2005.00631.x

G. Monsel, A. Canestri, and E. Caumes, Antibiothérapie de la phase primaire de la borréliose de Lyme, Médecine Mal Infect. juill, vol.37, issue.7-8, pp.463-72, 2007.

J. D. Radolf, M. V. Norgard, M. E. Brandt, R. D. Isaacs, P. A. Thompson et al., Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis, J Immunol Baltim Md, vol.147, issue.6, pp.1968-74, 1950.

Y. Negussie, Detection of plasma tumor necrosis factor, interleukins 6, and 8 during the Jarisch-Herxheimer Reaction of relapsing fever, J Exp Med. 1 mai, vol.175, issue.5, pp.1207-1219, 1992.

H. W. Meislin and J. C. Bremer, Jarisch-Herxheimer reaction. Case report, JACEP. oct, vol.5, issue.10, pp.779-81, 1976.

R. B. Nadelman, S. W. Luger, E. Frank, M. Wisniewski, J. J. Collins et al., Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease, Ann Intern Med. 15 août, vol.117, issue.4, pp.273-80, 1992.

, Nouvelle approche sur la maladie de lyme conseils pour le diagnostic et protocole de traitement de la maladie de lyme et des autres maladies transmises par les tiques. Traduction validée par le conseil de l'ILADS, p.33, 2005.

E. M. Massarotti, S. W. Luger, D. W. Rahn, R. P. Messner, J. B. Wong et al., Treatment of early lyme disease, Am J Med. avr, vol.92, issue.4, pp.396-403, 1992.

L. L. Dever, J. H. Jorgensen, and A. G. Barbour, In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies, J Clin Microbiol, vol.30, issue.10, pp.2692-2697, 1992.

M. Martinot, Bases microbiologiques et pharmacologiques du traitement de la borréliose de Lyme. Traitement et suivi de la phase aiguë (érythème migrant), Médecine Mal Infect. juill, vol.37, issue.7-8, pp.394-409, 2007.
DOI : 10.1016/j.medmal.2006.01.028

K. Hunfeld, P. Kraiczy, T. A. Wichelhaus, V. Schäfer, and V. Brade, Colorimetric in vitro susceptibility testing of penicillins, cephalosporins, macrolides, streptogramins, tetracyclines, and aminoglycosides against Borrelia burgdorferi isolates, Int J Antimicrob Agents, vol.15, issue.1, pp.11-17, 2000.

D. Terekhova, M. L. Sartakova, G. P. Wormser, I. Schwartz, and F. C. Cabello, Erythromycin Resistance in Borrelia burgdorferi, Antimicrob Agents Chemother, vol.46, issue.11, pp.3637-3677, 2002.
DOI : 10.1128/aac.46.11.3637-3640.2002

URL : https://aac.asm.org/content/46/11/3637.full.pdf

N. S. Zeidner, K. S. Brandt, E. Dadey, M. C. Dolan, C. Happ et al., Sustained-Release Formulation of Doxycycline Hyclate for Prophylaxis of Tick Bite Infection in a Murine Model of Lyme Borreliosis, Antimicrob Agents Chemother. 1 juill, vol.48, issue.7, pp.2697-2706, 2004.

B. J. Luft, D. J. Volkman, J. J. Halperin, and R. J. Dattwyler, New chemotherapeutic approaches in the treatment of Lyme borreliosis, Ann N Y Acad Sci, vol.539, issue.1, pp.352-361, 1988.

V. P. Mursic, U. Busch, W. Marget, D. P. Rigler, and S. Hagl, Kill kinetics ofBorrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis, Infection, vol.24, issue.1, pp.9-16, 1996.

F. Van-bambeke, G. B. Ninane, and P. Rationnels, Louvain Med, vol.117, pp.375-388, 1998.

C. Müller, A. Netland, A. F. Dawson, and A. E. , The penetration of cefuroxime into the cerebrospinal fluid through inflamed and noninflamed meninges, J Antimicrob Chemother, vol.6, issue.2, pp.279-283, 1980.

S. R. Norrby, K. Alestig, A. Forsgren, C. E. Nord, and . Doxycycline-revisited, Proceedings of a Symposium Held, vol.20, pp.1-79, 1987.

J. Boerner, K. Failing, and M. M. Wittenbrink, In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: influence of test conditions on minimal inhibitory concentration (MIC) values, Zentralblatt Für Bakteriol, vol.283, issue.1, pp.49-60, 1995.

K. Hunfeld, P. Kraiczy, E. Kekoukh, V. Schäfer, and V. Brade, Standardised in vitro susceptibility testing of Borrelia burgdorferi against well-known and newly developed antimicrobial agents-possible implications for new therapeutic approaches to Lyme disease, Int J Med Microbiol IJMM. juin, vol.291, pp.125-162, 2002.

M. S. Klempner, L. T. Hu, J. Evans, C. H. Schmid, G. M. Johnson et al., Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease, N Engl J Med, vol.345, issue.2, pp.85-92, 2001.

A. Berende, H. Hofstede, F. J. Vos, H. Van-middendorp, M. L. Vogelaar et al., Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease, N Engl J Med. 31 mars, vol.374, issue.13, pp.1209-1229, 2016.

I. Horowitz and R. , The Use of Dapsone as a Novel « Persister » Drug in the Treatment of Chronic Lyme Disease/Post Treatment Lyme Disease Syndrome, J Clin Exp Dermatol Res, issue.03, p.7, 2016.

J. Clarissou, A. Song, C. Bernede, D. Guillemot, A. Dinh et al., Efficacy of a long-term antibiotic treatment in patients with a chronic Tick Associated Poly-organic Syndrome (TAPOS), Médecine Mal Infect. févr, vol.39, issue.2, pp.108-123, 2009.

S. T. Donta, Macrolide therapy of chronic Lyme disease, Med Sci Monit, vol.9, issue.11, pp.136-142, 2003.

B. A. Fallon, J. G. Keilp, K. M. Corbera, E. Petkova, C. B. Britton et al., A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy, Neurology, vol.70, issue.13, pp.992-1003, 2008.

L. B. Krupp, L. G. Hyman, R. Grimson, P. K. Coyle, P. Melville et al., Study and treatment of post Lyme disease (STOP-LD) A randomized double masked clinical trial, Neurology, vol.60, issue.12, pp.1923-1930, 2003.

C. Perronne, Critical review of studies trying to evaluate the treatment of chronic Lyme disease, Presse Médicale. juill, vol.44, issue.7-8, pp.828-859, 2015.

J. Feng, W. Shi, S. Zhang, and Y. Zhang, Identification of new compounds with high activity against stationary phase Borrelia burgdorferi from the NCI compound collection, Emerg Microbes Infect. 3 juin, vol.4, issue.5, p.31, 2015.

J. Feng, S. Zhang, W. Shi, and Y. Zhang, Activity of Sulfa Drugs and Their Combinations against Stationary Phase B. burgdorferi In Vitro, Antibiotics. 22 mars, vol.6, issue.1, p.10, 2017.

B. Sharma, A. V. Brown, N. E. Matluck, L. T. Hu, and K. Lewis, Borrelia burgdorferi, the Causative Agent of Lyme Disease, Forms Drug-Tolerant Persister Cells, Antimicrob Agents Chemother. août, vol.59, issue.8, pp.4616-4640, 2015.

J. Feng, P. G. Auwaerter, and Y. Zhang, Drug Combinations against Borrelia burgdorferi Persisters In Vitro: Eradication Achieved by Using Daptomycin, Cefoperazone and Doxycycline, Brissette CA, éditeur. PLOS ONE. 25 mars, vol.10, issue.3, p.117207, 2015.

G. P. Wormser, Controversies in the use of antimicrobials for the prevention and treatment of Lyme disease, Infection, vol.24, issue.2, pp.178-181, 1996.

S. Warshafsky, J. Nowakowski, R. B. Nadelman, R. S. Kamer, S. J. Peterson et al., Efficacy of antibiotic prophylaxis for prevention of Lyme disease, J Gen Intern Med. juin, vol.11, issue.6, pp.329-362, 1996.

E. I. Korenberg, H. G. Moskvitina, N. N. Vorobyeva, and L. Y. Gorban, Prevention of borreliosis in persons bitten by infected ticks, Infection, vol.24, issue.2, pp.187-189, 1996.

R. B. Nadelman, J. Nowakowski, D. Fish, R. C. Falco, K. Freeman et al., Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite, N Engl J Med, vol.345, issue.2, pp.79-84, 2001.

P. A. Schlesinger, P. H. Duray, B. A. Burke, A. C. Steere, and M. T. Stillman, Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi, Ann Intern Med. juill, vol.103, issue.1, pp.67-75, 1985.

D. J. Elliott, S. C. Eppes, and J. D. Klein, Teratogen update: Lyme disease, Teratology, vol.64, issue.5, pp.276-281, 2001.

G. P. Wormser, R. J. Dattwyler, E. D. Shapiro, J. J. Halperin, A. C. Steere et al., The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America, 2006.

D. J. Cameron, L. B. Johnson, and E. L. Maloney, Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent diseaseILADS 2014, Expert Rev Anti Infect Ther. sept, vol.12, issue.9, pp.1103-1138, 2014.

E. European, Union of Concerted Action on Lyme Borreliosis

. Disponible,

S. Craft, J. E. Desanna, E. T. , and M. Se, Treatment of the early manifestations of Lyme disease, Ann Intern Med, vol.99, pp.22-26, 1983.

M. Å. Ljøstad, U. Fingerle, V. Rupprecht, T. Schmutzhard, E. Steiner et al., EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis: Guidelines on neuroborreliosis, Eur J Neurol. janv, vol.17, issue.1, pp.8-12, 2010.

U. Ljøstad, E. Skogvoll, R. Eikeland, R. Midgard, T. Skarpaas et al., Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial, Lancet Neurol, vol.7, issue.8, pp.690-695, 2008.

A. C. Steere, Neurologic Abnormalities of Lyme Disease: Successful Treatment with High-Dose Intravenous Penicillin, Ann Intern Med. 1 déc, vol.99, issue.6, p.767, 1983.

R. A. Kalish, R. F. Kaplan, E. Taylor, L. Jones-woodward, K. Workman et al., Evaluation of study patients with Lyme disease, 10-20-year follow-up, J Infect Dis, vol.183, issue.3, pp.453-460, 2001.

R. Eikeland, U. Ljøstad, M. Å. Herlofson, K. Løhaugen, and G. C. , European neuroborreliosis: neuropsychological findings 30 months posttreatment: European neuroborreliosis, Eur J Neurol. mars, vol.19, issue.3, pp.480-487, 2012.
DOI : 10.1111/j.1468-1331.2011.03563.x

URL : https://bora.uib.no/bitstream/1956/5868/1/European%20neuroborreliosis.pdf

U. Ljøstad and M. , Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors: Treatment for acute Lyme neuroborreliosis, Eur J Neurol. janv, vol.17, issue.1, pp.118-141, 2010.

R. Eikeland, M. Å. Herlofson, K. Ljøstad, and U. , European neuroborreliosis: quality of life 30 months after treatment: European LNB, quality of life, Acta Neurol Scand, vol.124, issue.5, pp.349-54, 2011.

T. Benke, T. Gasse, M. Hittmair-delazer, and E. Schmutzhard, Lyme encephalopathy: long-term neuropsychological deficits years after acute neuroborreliosis, Acta Neurol Scand, vol.91, issue.5, pp.353-357, 1995.
DOI : 10.1111/j.1600-0404.1995.tb07020.x

D. Bagger-sjöbäck, S. Remahl, and M. Ericsson, Long-term outcome of facial palsy in neuroborreliosis, Otol Neurotol, vol.26, issue.4, pp.790-795, 2005.

L. P. Yu, D. B. Burr, K. D. Brandt, O. Connor, B. L. Rubinow et al., Effects of oral doxycycline administration on histomorphometry and dynamics of subchondral bone in a canine model of osteoarthritis, J Rheumatol. janv, vol.23, issue.1, pp.137-179, 1996.

A. C. Steere, R. E. Levin, P. J. Molloy, R. A. Kalish, A. Iii et al., Treatment of Lyme arthritis, Arthritis Rheumatol, vol.37, issue.6, pp.878-888, 1994.

H. Valesová, J. Mailer, J. Havlík, D. Hulínská, and J. Hercogová, Long-term results in patients with Lyme arthritis following treatment with ceftriaxone, Infection. févr, vol.24, issue.1, pp.98-102, 1996.

B. E. Daikh, F. E. Emerson, R. P. Smith, F. L. Lucas, and C. A. Mccarthy, Lyme Arthritis: A Comparison of Presentation, Synovial Fluid Analysis, and Treatment Course in Children and Adults: Analysis and Treatment of Lyme Arthritis in Children and Adults, Arthritis Care Res. déc, vol.65, issue.12, pp.1986-90, 2013.

A. C. Steere, W. Klitz, E. E. Drouin, B. A. Falk, W. W. Kwok et al., Antibiotic-refractory Lyme arthritis is associated with HLA-DR molecules that bind a Borrelia burgdorferi peptide, J Exp Med. 17 avr, vol.203, issue.4, pp.961-71, 2006.

A. T. Borchers, C. L. Keen, A. C. Huntley, and M. E. Gershwin, Lyme disease: A rigorous review of diagnostic criteria and treatment, J Autoimmun. févr, vol.57, pp.82-115, 2015.

V. Preac-mursic, B. Wilske, B. Gross, K. Weber, H. W. Pfister et al., Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis, Infection, vol.17, issue.6, pp.355-359, 1989.

J. F. Bradley, R. C. Johnson, and J. L. Goodman, The persistence of spirochetal nucleic acids in active Lyme arthritis, Ann Intern Med. 15 mars, vol.120, issue.6, pp.487-496, 1994.

T. Bankhead and G. Chaconas, The role of VlsE antigenic variation in the Lyme disease spirochete: persistence through a mechanism that differs from other pathogens, Mol Microbiol. sept, vol.65, issue.6, pp.1547-58, 2007.

J. Zhang, J. M. Hardham, A. G. Barbour, and S. J. Norris, Antigenic variation in Lyme disease borreliae by promiscuous recombination of VMP-like sequence cassettes, Cell, vol.89, issue.2, pp.275-285, 1997.

A. S. Rogovskyy and T. Bankhead, Variable VlsE is critical for host reinfection by the Lyme disease spirochete, PloS One, vol.8, issue.4, p.61226, 2013.

K. J. Indest, R. Ramamoorthy, and M. T. Philipp, Transcriptional regulation in spirochetes, J Mol Microbiol Biotechnol, vol.2, issue.4, pp.473-482, 2000.

P. M. Arnaboldi, M. Sambir, and R. J. Dattwyler, Decorin Binding Proteins A and B in the Serodiagnosis of Lyme Disease in North America, Clin Vaccine Immunol, vol.21, issue.10, pp.1426-1462, 2014.

E. Fikrig, W. Feng, S. W. Barthold, S. R. Telford, and R. A. Flavell, Arthropod-and Host-Specific Borrelia burgdorferi bbk32 Expression and the Inhibition of Spirochete Transmission, J Immunol. 15 mai, vol.164, issue.10, pp.5344-51, 2000.

B. Wilske, V. Preac-mursic, S. Jauris, A. Hofmann, I. Pradel et al., Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi, Infect Immun. mai, vol.61, issue.5, pp.2182-91, 1993.

S. Molin and T. Tolker-nielsen, Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure, Curr Opin Biotechnol. juin, vol.14, issue.3, pp.255-61, 2003.

A. Alitalo, T. Meri, P. Comstedt, L. Jeffery, J. Tornberg et al., Expression of complement factor H binding immunoevasion proteins in Borrelia garinii isolated from patients with neuroborreliosis, Eur J Immunol, vol.35, issue.10, pp.3043-3053, 2005.

H. Ma and J. D. Bryers, Non-invasive determination of conjugative transfer of plasmids bearing antibiotic-resistance genes in biofilm-bound bacteria: effects of substrate loading and antibiotic selection, Appl Microbiol Biotechnol. janv, vol.97, issue.1, pp.317-345, 2013.

N. Ramamoorthi, S. Narasimhan, U. Pal, F. Bao, X. F. Yang et al., The Lyme disease agent exploits a tick protein to infect the mammalian host, Nature. 28 juill, vol.436, issue.7050, pp.573-580, 2005.

F. T. Liang, M. B. Jacobs, L. C. Bowers, and M. T. Philipp, An immune evasion mechanism for spirochetal persistence in Lyme borreliosis, J Exp Med, vol.195, issue.4, pp.415-422, 2002.
DOI : 10.1084/jem.20011870

URL : http://jem.rupress.org/content/195/4/415.full.pdf

J. Anguita, N. Ramamoorthi, J. W. Hovius, S. Das, V. Thomas et al., Salp15, an Ixodes scapularis salivary protein, inhibits CD4+ T cell activation, Immunity, vol.16, issue.6, pp.849-859, 2002.
DOI : 10.1016/s1074-7613(02)00325-4

URL : https://doi.org/10.1016/s1074-7613(02)00325-4

O. Onder, P. T. Humphrey, B. Mcomber, F. Korobova, N. Francella et al., OspC Is Potent Plasminogen Receptor on Surface of Borrelia burgdorferi, J Biol Chem. 11 mai, vol.287, issue.20, pp.16860-16868, 2012.

V. Lagal, ?. Portno, G. Faure, D. Postic, and G. Baranton, Borrelia burgdorferi sensu stricto invasiveness is correlated with OspC?plasminogen affinity, Microbes Infect. mars, vol.8, issue.3, pp.645-52, 2006.
DOI : 10.1016/j.micinf.2005.08.017

D. J. Grab, G. Perides, J. S. Dumler, K. J. Kim, J. Park et al., Borrelia burgdorferi, Host-Derived Proteases, and the Blood-Brain Barrier, Infect Immun. 1 févr, vol.73, issue.2, pp.1014-1036, 2005.
DOI : 10.1128/iai.73.4.2569.2005

URL : https://iai.asm.org/content/73/4/2569.full.pdf

S. E. Malawista and A. De-boisfleury-chevance, Clocking the Lyme Spirochete. Ausubel F, éditeur, PLoS ONE. 20 févr, vol.3, issue.2, p.1633, 2008.

K. Zhang, J. Liu, Y. Tu, H. Xu, N. W. Charon et al., Two CheW coupling proteins are essential in a chemosensory pathway of Borrelia burgdorferi: Borrelia burgdorferi chemotaxis, Mol Microbiol. août, vol.85, issue.4, pp.782-94, 2012.

B. P. Guo, E. L. Brown, D. W. Dorward, L. C. Rosenberg, and M. Höök, Decorinbinding adhesins from Borrelia burgdorferi, Mol Microbiol, vol.30, issue.4, pp.711-723, 1998.

F. C. Cabello, H. P. Godfrey, and S. A. Newman, Hidden in plain sight: Borrelia burgdorferi and the extracellular matrix, Trends Microbiol. août, vol.15, issue.8, pp.350-354, 2007.
DOI : 10.1016/j.tim.2007.06.003

URL : https://touroscholar.touro.edu/author_agreement.pdf

S. W. Barthold, M. S. Souza, J. L. Janotka, A. L. Smith, and D. H. Persing, Chronic Lyme borreliosis in the laboratory mouse, Am J Pathol. sept, vol.143, issue.3, pp.959-71, 1993.

C. A. Brissette, A. E. Cooley, L. H. Burns, S. P. Riley, A. Verma et al., Lyme borreliosis spirochete Erp proteins, their known host ligands, and potential roles in mammalian infection, Int J Med Microbiol. sept, vol.298, pp.257-67, 2008.
DOI : 10.1016/j.ijmm.2007.09.004

URL : http://europepmc.org/articles/pmc2596196?pdf=render

P. Kraiczy, C. Skerka, M. Kirschfink, V. Brade, and P. F. Zipfel, Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H, Eur J Immunol, vol.31, issue.6, pp.1674-1684, 2001.

M. Pausa, V. Pellis, M. Cinco, P. G. Giulianini, G. Presani et al., Serum-Resistant Strains of Borrelia burgdorferi Evade ComplementMediated Killing by Expressing a CD59-Like Complement Inhibitory Molecule, J Immunol. 15 mars, vol.170, issue.6, pp.3214-3236, 2003.

J. K. Franz and A. Krause, Lyme disease (Lyme borreliosis), Best Pract Res Clin Rheumatol, vol.17, issue.2, pp.241-264, 2003.